DealKillShot delivers decision-grade regulatory risk memos for PE deal teams evaluating $20M–$850M transactions — at 1/10th the cost of Big Law, before LOI.
The tools you have cost too much, take too long, or deliver the wrong output at the wrong stage of the deal.
| Big Law Firm | Expert Network | Internal Analyst | DealKillShot | |
|---|---|---|---|---|
| Deal Stage | Post-LOI | Pre-LOI | IC prep | Pre-LOI / IOI |
| Turnaround | 3–8 weeks | 1 hour (no deliverable) | Weeks | 24–72 hours |
| Cost | $75K–$200K+ | $1,500–$5,000 | Headcount + weeks | $500–$15,000 |
| Output | Legal memo | Verbal opinion | Slides, maybe | Decision memo + Go/No-Go |
| Scope | Deep, narrow | Narrow | Surface | Multi-agency, cross-border |
No retainer. No engagement letter. No 90-day timeline. Submit. Pay. Receive.
Target company, acquirer, deal size, jurisdictions, and the question keeping your IC up at night. 8 minutes.
Instant confirmation. $500 screens process without committee approval — your associate can order and expense it today.
FTC enforcement database, DOJ merger guidelines, CFIUS annual reports, EU merger registry, CADE/ANATEL filings, state AG actions, new mini-HSR statutes. Cross-referenced against live enforcement posture.
The Kill-Shot Memo: every regulatory vector that can delay, restructure, or destroy this deal — with precedent comparables, timeline impact, and a clear Go / No-Go / Proceed-with-Conditions. IC-ready on arrival.
Real transactions. Real enforcement. Real losses. Every one of these was identifiable before LOI — with the right scan.
Centerbridge bet $835M on combining the two largest IDD providers in the country. The thesis looked clean — until the FTC carved out 128 facilities across Indiana, Louisiana, and Texas. A 10-year acquisition ban in affected markets followed. The deal closed, but not the deal they underwrote.
Welsh Carson built USAP from scratch in 2012. Bought nearly every major anesthesia group in Texas. Controlled pricing. Then the FTC came — consent order, frozen equity, single board seat, and mandatory pre-approval for any future physician acquisitions nationwide. Colorado's AG piled on: five hospital divestitures plus $200K restitution. The federal case against USAP is still live today.
Aya moved to acquire Cross Country — two of the largest healthcare staffing platforms in the US. The FTC identified significant competitive concerns and signaled a formal challenge. A 43-day government shutdown extended the HSR review past the deal's termination date. Aya pulled the plug in December 2025. Legal fees burned. Management distracted for months. Pipeline frozen. $20M termination fee paid. The deal team saw the competitive overlap — but missed the enforcement timing.
Get a preliminary risk score for your deal in 30 seconds. No cost. No commitment.
Enter your deal parameters. Scores based on current enforcement patterns, filing thresholds, and sector-specific regulatory exposure.
Every tier delivers the full DealKillShot methodology. Pick the scope that matches your deal.
Deals $20M–$200M. 48-hour preliminary kill-shot check. Is there a show-stopper hiding in this deal? You'll know before your next IC meeting.
Deals $200M–$500M. Full regulatory kill-shot memo. FTC, DOJ, CFIUS, state AGs, sector regulators. Decision-grade output for your IC.
Deals $500M–$850M. Comprehensive cross-border, multi-regime analysis. IEEPA/tariff, EU AI Act, CFIUS, HSR second-request risk. Full IC-grade deliverable.
Bilateral regulatory sweep for deals in the $200M–$500M range requiring multi-jurisdiction coverage. US agencies plus EU DG Competition, FSR, or CADE/ANATEL.
Stop buying one-off screens. Your active deal pipeline gets continuous regulatory monitoring — monthly sector briefings, priority 48-hour turnaround on every new deal screen, and real-time alerts when enforcement shifts impact live deals or portfolio companies. One caught kill-shot pays for a year.
Cancel anytime. No lock-in. Auto-renews.
Your deal doesn't stop at one border. Neither does our intelligence.
EU AI Act, Foreign Subsidies Regulation, national FDI screening, DG Competition merger review.
CFIUS review, FTC/DOJ antitrust, export controls, state-level merger notifications.
CADE antitrust, ANATEL telecom, LGPD data protection, CFIUS.
CFIUS mandatory declaration, EU FDI screening, entity list exposure, export controls.
CFIUS sovereign wealth scrutiny, FSR notification, national security assessment.
CADE (Brazil), SIC (Colombia), COFECE (Mexico). Spanish/Portuguese filings.
Cross-border regulatory analyst with operational presence in the US, Brazil, and Latin America. Trilingual (English, Portuguese, Spanish) — which means your CADE filing, ANATEL review, or SIC assessment doesn't route through a translator. Built DealKillShot because $20M–$850M deals keep dying from regulatory vectors that Big Law catches at $200K and 8 weeks — or doesn't catch at all until closing.
The product exists for one reason: middle-market PE teams need a regulatory risk scan at the IOI stage, at a price that doesn't require committee approval, delivered before the next IC meeting. No one was building that. Now someone is.
We'll respond within 24 hours with an initial risk flag. No engagement required. Confidential.
The partners who find it at the IOI stage spend $500–$15,000. The ones who find it at the closing table spend $5M — and explain it to their LPs.
Effective Date: February 2026. This policy describes how Protocol Logic LLC ("Provider," "we") collects, uses, and protects information from DealKillShot clients ("Client," "you").
1. Information We Collect. We collect the information you provide directly: name, email address, company/firm name, deal parameters (sector, size, jurisdictions), and deal descriptions submitted through our intake form, Risk Scanner tool, or payment process. Payment information (credit card, billing address) is processed and stored by Stripe, Inc. — we do not store payment card details on our servers.
2. How We Use Your Information. We use Client information exclusively to: (a) deliver purchased Reports and services, (b) communicate about active engagements, (c) send regulatory alerts to retainer/subscription clients, and (d) improve our analytical methodology using anonymized, aggregated data. We do not use Client information for advertising, marketing to third parties, or any purpose unrelated to service delivery.
3. Deal Confidentiality. All deal-specific information — including target company names, deal sizes, acquisition structures, and regulatory concerns — is treated as strictly confidential. We will never disclose deal details to any third party, including other clients, without your explicit written consent. This obligation survives termination of any engagement.
4. Information Sharing. We do not sell, rent, or trade your personal or deal information. We share information only with: (a) Stripe, Inc. for payment processing, (b) Calendly for appointment scheduling (if you book a call), and (c) as required by law, regulation, or valid legal process.
5. Data Retention. We retain Client information and delivered Reports for 24 months following the last engagement, after which data is securely deleted. Clients may request earlier deletion by emailing [email protected]. Anonymized analytical data (sector trends, risk patterns) may be retained indefinitely.
6. Data Security. We use industry-standard security measures including encrypted email communications (Proton Mail), secure payment processing (Stripe PCI-DSS Level 1), and access controls limiting deal information to the assigned analyst. No internet transmission is 100% secure; we cannot guarantee absolute security but take all reasonable precautions.
7. Cookies and Analytics. The DealKillShot website uses minimal cookies required for site functionality. We use basic analytics to understand site traffic. The Risk Scanner tool stores no data server-side — all scoring occurs in your browser. Email addresses submitted through the Risk Scanner are used solely to send results and relevant regulatory updates.
8. Your Rights. You may at any time: (a) request access to all personal information we hold about you, (b) request correction of inaccurate information, (c) request deletion of your information, or (d) opt out of any non-essential communications. Contact [email protected] for any of these requests. We will respond within 30 days.
9. International Transfers. Provider operates from the United States. If you are located outside the US, your information will be transferred to and processed in the United States. By using our services, you consent to this transfer.
10. Changes. We may update this policy periodically. Material changes will be communicated via email to active clients. Continued use of services after changes constitutes acceptance.
1. Service Provider. DealKillShot is a proprietary intelligence product of Protocol Logic LLC, a Wyoming limited liability company ("Provider"). By purchasing any DealKillShot service, you ("Client") agree to these terms.
2. Scope of Service. DealKillShot delivers regulatory risk intelligence assessments ("Reports") based on publicly available enforcement data, regulatory filings, and sector-specific analysis. Reports are delivered as PDF documents to the email address provided at intake.
3. Not Legal Advice. Reports constitute regulatory intelligence analysis, not legal advice. Provider is not a law firm and does not provide legal representation. Client should consult qualified legal counsel before making transaction decisions based on Report findings.
4. Delivery Timeline. Diagnostic Screens: 24–48 business hours. Standard Kill-Shot Memos: 72 business hours. Premium Kill-Shot Memos: 72 business hours. Cross-Border Memos: 72 business hours. Timelines begin upon payment confirmation and receipt of complete intake information.
5. Payment. All fees are due at time of purchase via Stripe. Prices are in USD. Applicable taxes are collected automatically.
6. Refund Policy. If Provider cannot deliver the Report within the stated timeline, Client may request a full refund. Once a Report has been delivered, no refunds will be issued. If Client provides incomplete or materially inaccurate intake information that prevents Report completion, Provider will request clarification; failure to respond within 5 business days may result in forfeiture of fees.
7. Confidentiality. Provider treats all Client deal information as strictly confidential. Intake details, deal parameters, and Report contents will not be disclosed to any third party without Client's written consent. Provider may retain anonymized and aggregated data for internal research purposes.
8. Limitation of Liability. Provider's total liability for any claim arising from a Report shall not exceed the fee paid for that specific Report. Provider is not liable for investment decisions, transaction outcomes, or regulatory actions resulting from Client's use of Report findings.
9. Subscription Terms. Quarterly Retainer and Monthly Radar subscriptions auto-renew at the stated interval. Client may cancel at any time; cancellation takes effect at the end of the current billing period. No partial refunds for unused portions of a billing period.
10. Intellectual Property. Reports are licensed for Client's internal use only. Client may share Reports with their investment committee, legal counsel, and direct deal team members. Redistribution, resale, or publication of Reports is prohibited.
11. Governing Law. These terms are governed by the laws of the State of Wyoming. Any disputes shall be resolved through binding arbitration in Wyoming.